Anto Bagic

last updated 9/12/2017

Anto I. Bagic

Professor of Neurology and Chief of Epilepsy Division at UPMC Health Plan Inc

600 Grant Street, Pittsburgh, Pennsylvania, United States
HQ Phone:
(877) 563-0292

General Information


Professor of Neurology and Chief of Epilepsy Division - UPMC

Chief And Director - UPMC MyHealth

Chief, Epilepsy Division - University of Pittsburgh





Board Member - National Association of Epilepsy Centers

Founding Board Member - American Clinical MEG Society

Recent News

As explained by epilepsy specialist Dr. Anto Bagic at the University of Pittsburgh, the FDA mandates only a set of factors defining the pharmaceutical equivalence of a brand drug and its generic formulations.
The FDA requires the same amount and purity of active ingredients in both. Chief of the Epilepsy Division of the University of Pittsburgh Medical Center and director of the University of Pittsburgh Comprehensive Epilepsy Center, Dr. Bagic said that, technically speaking, for a generic product to be considered equivalent it has to have a similar measurements of the medication's distribution in the body and the medication's rate of reaching its greatest concentration in the bloodstream. "Since antiseizure medications must be maintained at a certain therapeutic level in a patient's bloodstream, a switch from a brand-name to a generic drug or between generic versions can have various undesired results," he said. "When a generic is approved there is an FDA process they go through, but they are never compared with each other," Dr. Bagic said. Dr. Bagic said he has seen the problem for the past few decades, as older antiepileptic medications became generic. Dr. Bagic himself has a patient who had been stable for more than a year and then experienced a seizure three or four weeks after she switched to a generic medication. But before a doctor can blame the generic, Dr. Bagic said, other issues must be considered: "Has she been taking her medication regularly? "Fortunately, most patients have no problems associated with the switch," Dr. Bagic said. Dr. Bagic added that patients should also involve their pharmacist and document the manufacturer and lot number of their generic medication. Then, unwanted results could be reported to the FDA.

Read More

Anto Bagic, M.D., Ph.D.
University of Pittsburgh Comprehensive Epilepsy Center (UPCEC)

Read More
NAEC's Board of Directors

Anto Bagic, M.D, Ph.D.
University of Pittsburgh Comprehensive Epilepsy Center (UPCEC)

Read More

Browse ZoomInfo’s Directories